In modern drug development, complexity is a given. Multiple endpoints, competing priorities, and increasing operational demands mean that clinical trial design must strike the right balance between effort, cost, and scientific rigor.
In this conference poster, Avie‑Lee Tillotson, Principal Statistician, explores how different levels of statistical and operational effort impact study design decisions and ultimately, trial success.
By applying robust biostatistics and biometrics approaches, this work highlights how thoughtful planning can:
- Optimize clinical trial efficiency
- Balance resource constraints and study complexity
- Improve decision-making in clinical development
- Reduce the risk of costly trial redesigns
With the right biometrics expertise and scalable support from a specialized clinical research organization (CRO), sponsors can design smarter trials that deliver reliable results, without unnecessary effort or risk. Click on the poster below to learn more.
